Tag: Arzeda

This is an algorithm, that is alive: The rise of Arzeda and Digital Biology

This is an algorithm, that is alive: The rise of Arzeda and Digital Biology

December 7, 2017 |

The question is being raised all over Silicon Valley — and increasingly around the world — if biotechnology is essentially a branch of information technology. 3D printing is one of those technologies that tests the boundaries between the digital and the physical worlds. Consider the images above you. On the upper left, an algorithm. On the […]

Read More

Engage the hyper-drive: Synbio’s fastest are going faster, bigger as Kytopen, Ginkgo, Twist Biosciences, Arzeda, TeselaGen feel the need for speed

Engage the hyper-drive: Synbio’s fastest are going faster, bigger as Kytopen, Ginkgo, Twist Biosciences, Arzeda, TeselaGen feel the need for speed

October 9, 2017 |

ENGAGE THE HYPER-DRIVE. Is everyone’s organism for making fuels, chemicals, materials, foods, flavors, fragrances and therapeutics — beautifully and slowly — heading for rapid obsolescence? “Everyone wants to make it faster,” notes Kytopen co-founder Cullen Buie. “Over the past 18 months, we discovered there’s a huge market for speed.” That’s one of the reasons why, […]

Read More

Arzeda Pumps It Up with Big Series A Funding

Arzeda Pumps It Up with Big Series A Funding

July 22, 2017 |

In Washington, Arzeda raised $12 million in a Series A round of funding, moving it forward on scaling up of their advanced protein design technology that is used for production of a range of chemicals and materials. The funding came from OS Fund, Bioeconomy Capital, Sustainable Conversion Ventures, and WRF Capital and will help beef […]

Read More

Protein, pathway design: The Digest’s 2017 Multi-Slide Guide to Arzeda

Protein, pathway design: The Digest’s 2017 Multi-Slide Guide to Arzeda

May 22, 2017 |

Arzeda’s proprietary technology combines targeted computational enzyme design and protein optimization with state-of-the-art metabolic bioengineering to create entirely novel designer cell factories capable of industry-scale chemical production. CEO Alex Zanghellini gave this illuminating overview of Arzeda’s breakthrough technology at ABLC 2017 in Washington, DC.

Read More

Reinventing enzymes, molecules by design: The Digest’s 2016 Multi-Slide Guide to Arzeda

Reinventing enzymes, molecules by design: The Digest’s 2016 Multi-Slide Guide to Arzeda

November 13, 2016 |

Arzeda’s proprietary technology combines targeted computational enzyme design and protein optimization with state-of-the-art metabolic bioengineering to create entirely novel designer cell factories capable of industry-scale chemical production. CEO Alex Zanghellini gave this overview of Arzeda’s breakthrough technology at ABLC Next in San Francisco.

Read More

Arzeda produces 2 keystone molecules for Amyris-DARPA project

Arzeda produces 2 keystone molecules for Amyris-DARPA project

November 4, 2016 |

At ABLC Next in California, Arzeda reached a major technical milestone with Amyris as a part of a Defense Advanced Research Projects Agency (DARPA) Technology Investment Agreement. Arzeda’s high-throughput, automated pipeline for protein engineering and pathway discovery has been validated by the production of two keystone molecules which will now be further optimized by Amyris. […]

Read More

Arzeda, Zymergen ink pact to develop advanced, novel molecules

Arzeda, Zymergen ink pact to develop advanced, novel molecules

March 28, 2016 |

In Washington state, Zymergen and Arzeda have signed a multi-year agreement to develop strains and processes to manufacture novel, high utility molecules and materials utilizing Arzeda’s pathway and enzyme design and Zymergen’s strain construction capabilities. “The development of new materials was a major driver of technological development over the course of the 20th century.  Biology has the […]

Read More

INVISTA and Arzeda enter agreement to develop bio-derived raw materials

INVISTA and Arzeda enter agreement to develop bio-derived raw materials

February 7, 2013 |

In Switzerland, INVISTA Technologies and Arzeda Corp. announced a collaboration for the development of new technologies to enable novel bio-derived processes. The initial focus of the collaboration will be on the production of bio-derived butadiene. The agreement brings together complementary technologies: INVISTA’s capabilities in biotechnology and catalysis, and knowledge of the chemicals industry; and Arzeda’s unique […]

Read More